Sign up Australia
Proactive Investors - Run By Investors For Investors

Zelda Therapeutics enters medical cannabis research partnership

The halt will remain in place until Tuesday 12th December 2017.
Zelda Therapeutics enters medical cannabis research partnership
The company's shares are in pre-open

Zelda Therapeutics Ltd (ASX:ZLD) continues to advance its medical cannabis strategy, and the company entered a trading halt this morning pending details of a partnership with a US-based research institution.

READ: Zelda approved for Australia’s first medicinal cannabis trial targeting insomnia

The halt will remain in place until the opening of trade on Tuesday 12th December 2017, or earlier if an announcement is made to the market.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Related Articles

Cannabis leaf
Sat
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
Woman holding cannabis leaf
October 16 2018
Canadian subsidiary Crystal Mountain is expanding its range of hydroponics equipment to meet expected demand.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use